PDCD4 limits prooncogenic neuregulin-ErbB signaling

被引:0
|
作者
Juan Carlos Montero
Atanasio Pandiella
机构
[1] Instituto de Biología Molecular y Celular del Cáncer (CSIC) and CIBERONC,Institute of Biomedical Research of Salamanca (IBSAL)
来源
关键词
Neuregulin; ErbB receptors; Breast cancer; PDCD4;
D O I
暂无
中图分类号
学科分类号
摘要
The neuregulins and their ErbB/HER receptors play essential roles in mammalian development and tissue homeostasis. In addition, deregulation of their function has been linked to the pathogenesis of diseases such as cancer or schizophrenia. These circumstances have stimulated research into the biology of this ligand-receptor system. Here we show the identification of programmed cell death protein-4 (PDCD4) as a novel neuregulin-ErbB signaling mediator. Phosphoproteomic analyses identified PDCD4 as protein whose phosphorylation increased in cells treated with neuregulin. Mutagenesis experiments defined serine 67 of PDCD4 as a site whose phosphorylation increased upon activation of neuregulin receptors. Phosphorylation of that site promoted degradation of PDCD4 by the proteasome, which depended on exit of PDCD4 from the nucleus to the cytosol. Mechanistic studies defined mTORC1 and ERK1/2 as routes implicated in neuregulin-induced serine 67 phosphorylation and PDCD4 degradation. Functionally, PDCD4 regulated several important biological functions of neuregulin, such as proliferation, migration, or invasion.
引用
收藏
页码:1799 / 1815
页数:16
相关论文
共 50 条
  • [21] Programmed cell death 4 (PDCD4) regulates proinflammatory cytokine signaling in bacterial pneumonia
    Cohen, Taylor S.
    Prince, Alice
    CYTOKINE, 2013, 63 (03) : 255 - 255
  • [22] Dissecting the Roles of PDCD4 in Breast Cancer
    Cai, Qian
    Yang, Hsin-Sheng
    Li, Yi-Chen
    Zhu, Jiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway
    Horie, Takahiro
    Ono, Koh
    Nishi, Hitoo
    Nagao, Kazuya
    Kinoshita, Minako
    Watanabe, Shin
    Kuwabara, Yasuhide
    Nakashima, Yasuhiro
    Takanabe-Mori, Rieko
    Nishi, Eiichiro
    Hasegawa, Koji
    Kita, Toru
    Kimura, Takeshi
    CARDIOVASCULAR RESEARCH, 2010, 87 (04) : 656 - 664
  • [24] Function and modulation of Pdcd4 in ovarian cancer
    Liu, Stephanie S.
    Wei, Tina N.
    Chan, Karen K. L.
    Ngan, Hextan Y. S.
    CANCER RESEARCH, 2011, 71
  • [25] An evolutionarily conserved interaction of tumor suppressor protein Pdcd4 with the poly(A)-binding protein contributes to translation suppression by Pdcd4
    Fehler, Olesja
    Singh, Priyanka
    Haas, Astrid
    Ulrich, Diana
    Mueller, Jan P.
    Ohnheiser, Johanna
    Klempnauer, Karl-Heinz
    NUCLEIC ACIDS RESEARCH, 2014, 42 (17) : 11107 - 11118
  • [26] Neuregulin-ErbB4 signaling in the developing lung alveolus: a brief review
    Najla Fiaturi
    John J. Castellot
    Heber C. Nielsen
    Journal of Cell Communication and Signaling, 2014, 8 : 105 - 111
  • [27] Neuregulin-ErbB4 signaling in the developing lung alveolus: a brief review
    Fiaturi, Najla
    Castellot, John J., Jr.
    Nielsen, Heber C.
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2014, 8 (02) : 105 - 111
  • [28] Neuregulin-4 Induced ErbB4 Signaling in Macrophages Is Protective in DSS Colitis
    Schumacher, Michael
    Bernard, Jessica
    Hsieh, Jon
    Punit, Shivesh
    Frey, Mark
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S56 - S56
  • [29] Neuregulin/ErbB signaling in pregnancy-induced hypertrophy
    Lemmens, K.
    Doggen, K.
    De Keulenaer, G. W.
    EUROPEAN HEART JOURNAL, 2009, 30 : 460 - 461
  • [30] The role of Neuregulin-1β/ErbB signaling in the heart
    Pentassuglia, Laura
    Sawyer, Douglas B.
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (04) : 627 - 637